Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects

Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects

Immunotherapy is a new pillar of cancer therapy that provides novel opportunities to treat solid tumors. In this context, the development of new drugs targeting immune checkpoints is considered a promising approach in colorectal cancer (CRC) treatment because it can be induce specific and durable an...

Full description

Bibliographic Details
Main Authors: Shima Makaremi, Zahra Asadzadeh, Nima Hemmat, Amir Baghbanzadeh, Alessandro Sgambato, Farid Ghorbaninezhad, Hossein Safarpour, Antonella Argentiero, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris, Behzad Baradaran
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Biomedicines
Subjects:
cancer immunotherapy
immune checkpoints
colorectal cancer
monoclonal antibodies (mAbs)
Online Access:https://www.mdpi.com/2227-9059/9/9/1075

Internet

https://www.mdpi.com/2227-9059/9/9/1075

Similar Items